- Home
- VEON vs APLS Comparison
VEON vs APLS Comparison
Compare VEON & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEON
- APLS
- Stock Information
- Founded
- VEON 1992
- APLS 2009
- Country
- VEON United Arab Emirates
- APLS United States
- Employees
- VEON N/A
- APLS N/A
- Industry
- VEON Telecommunications Equipment
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- VEON Telecommunications
- APLS Health Care
- Exchange
- VEON Nasdaq
- APLS Nasdaq
- Market Cap
- VEON 2.7B
- APLS 2.2B
- IPO Year
- VEON 1996
- APLS 2017
- Fundamental
- Price
- VEON $46.39
- APLS $18.99
- Analyst Decision
- VEON Strong Buy
- APLS Buy
- Analyst Count
- VEON 1
- APLS 19
- Target Price
- VEON $60.00
- APLS $37.39
- AVG Volume (30 Days)
- VEON 285.3K
- APLS 1.9M
- Earning Date
- VEON 08-07-2025
- APLS 07-31-2025
- Dividend Yield
- VEON N/A
- APLS N/A
- EPS Growth
- VEON N/A
- APLS N/A
- EPS
- VEON 6.56
- APLS N/A
- Revenue
- VEON $4,088,000,000.00
- APLS $775,839,000.00
- Revenue This Year
- VEON $6.27
- APLS $1.01
- Revenue Next Year
- VEON $6.79
- APLS $22.14
- P/E Ratio
- VEON $6.60
- APLS N/A
- Revenue Growth
- VEON 8.84
- APLS 48.04
- 52 Week Low
- VEON $25.83
- APLS $16.10
- 52 Week High
- VEON $58.30
- APLS $42.47
- Technical
- Relative Strength Index (RSI)
- VEON 54.32
- APLS 53.27
- Support Level
- VEON $42.54
- APLS $17.35
- Resistance Level
- VEON $45.00
- APLS $18.60
- Average True Range (ATR)
- VEON 2.06
- APLS 0.71
- MACD
- VEON 0.57
- APLS 0.02
- Stochastic Oscillator
- VEON 97.91
- APLS 86.77
About VEON VEON Ltd. ADS
VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.